CompanyGraph
At a glance
- Depends onDownstream position: depends on 11 industries, supplies 6
- ScaleMarket cap is $1.05T, higher than 95% of all stocks globally
- FinancialsAltman Z-Score 9.29: safe zone
- Interpretations5 currently firing — 5
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.59%Below 5Y avg (0.89%)
Annual Rate
USD 6.92Paid quarterly
Payout Ratio
21.7%Sustainable
Consecutive Growth
11 yrStrong track record
Paying Dividends
27 yr
Last Ex-Dividend
Aug 14, 2026
Last Payment
Sep 10, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.05TUSDvs all stocks (USD)
Trailing P/E
41.85xRevenue (TTM)
79.67BUSDvs all stocks (USD)
Profit Margin
33.53%Beta
0.5060xvs all stocks
52-Week Change
60.68%vs all stocks
Forward Annual Dividend Yield
0.59%vs all stocks
Market Capitalization
1.05TUSDvs all stocks (USD)
Enterprise Value
1.15TUSDvs all stocks (USD)
Trailing P/E
41.85xForward P/E
26.12xPEG Ratio
1.59xPrice to Sales (TTM)
13.81xPrice to Book (MRQ)
32.46xEnterprise to Revenue
14.38xEnterprise to EBITDA
27.47xGross Margin
85.78%Profit Margin
33.53%Operating Margin
54.22%Return on Assets (TTM)
20.36%Return on Equity (TTM)
102.29%Revenue (TTM)
79.67BUSDvs all stocks (USD)
Revenue per Share (TTM)
89.02USDUpdated Aug 27, 2026Quarterly Revenue Growth
47.70%Gross Profit (TTM)
66.44BUSDvs all stocks (USD)
EBITDA (TTM)
49.25BUSDvs all stocks (USD)
Net Income (TTM)
26.71BUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
25.30%Operating Cash Flow (TTM)
28.08BUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
11.07BUSDvs all stocks (USD)
Forward Annual Dividend Rate
6.92USDUpdated Aug 27, 2026Forward Annual Dividend Yield
0.59%vs all stocks
Trailing Annual Dividend Rate
6.69USDUpdated Aug 27, 2026Trailing Annual Dividend Yield
0.57%vs all stocks
5-Year Average Dividend Yield
0.89%vs all stocks
Payout Ratio
21.69%Revenue
65.18BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
11.05BUSDFY2025 · Dec 31, 2025Gross Profit
54.13BUSDFY2025 · Dec 31, 2025Operating Income
29.70BUSDvs all stocks (USD)
Pre-tax Income
25.73BUSDFY2025 · Dec 31, 2025Income Tax Expense
5.09BUSDFY2025 · Dec 31, 2025Net Income
20.64BUSDFY2025 · Dec 31, 2025EBIT
29.70BUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
35.09BUSDFY2025 · Dec 31, 2025Research & Development
13.34BUSDFY2025 · Dec 31, 2025Selling, General & Administrative
11.09BUSDFY2025 · Dec 31, 2025EPS (Basic)
23.00USDFY2025 · Dec 31, 2025EPS (Diluted)
22.95USDFY2025 · Dec 31, 2025Basic Shares Outstanding
897.30MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
897.30MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
20.64BUSDFY2025 · Dec 31, 2025Operating Cash Flow
23.60BUSDFY2025 · Dec 31, 2025Free Cash Flow
15.76BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
7.27BUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
20.64BUSDFY2025 · Dec 31, 2025Depreciation & Amortization
2.00BUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-1.71BUSDFY2025 · Dec 31, 2025Stock-based Compensation
626.00MUSDFY2025 · Dec 31, 2025Other Non-cash Items
3.53BUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-7.00BUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
10.19BUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-4.67BUSDFY2025 · Dec 31, 2025Capital Expenditures
-7.84BUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
-2.79BUSDFY2025 · Dec 31, 2025Net Acquisitions
-661.00MUSDFY2025 · Dec 31, 2025Purchase of Investments
-645.00MUSDFY2025 · Dec 31, 2025Sale of Investments
964.00MUSDFY2025 · Dec 31, 2025Other Investing Activity
1.00MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-8.18BUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
13.17BUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-778.00MUSDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-4.34BUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-4.11BUSDFY2025 · Dec 31, 2025Common Dividends Paid
-5.38BUSDFY2025 · Dec 31, 2025Other Financing Charges
-772.00MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-2.21BUSDFY2025 · Dec 31, 2025Shares Outstanding
891.50MSharesUpdated Aug 27, 2026Float Shares
888.95MSharesUpdated Aug 27, 2026Shares Short
6.56MSharesUpdated Aug 27, 2026Short Ratio
2.46daysvs all stocks
Short % of Shares Outstanding
0.74%vs all stocks
% Held by Insiders
0.16%vs all stocks
% Held by Institutions
85.42%vs all stocks
Total Cash (MRQ)
8.95BUSDvs all stocks (USD)
Total Cash per Share (MRQ)
10.04USDUpdated Aug 27, 2026Total Debt (MRQ)
54.91BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
1.62xCurrent Ratio (MRQ)
1.35xBook Value per Share (MRQ)
38.00USDUpdated Aug 27, 2026Total Assets
112.48BUSDvs all stocks (USD)
Total Current Assets
55.63BUSDFY2025 · Dec 31, 2025Total Liabilities
85.94BUSDFY2025 · Dec 31, 2025Total Non-current Assets
56.85BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
50.71BUSDFY2025 · Dec 31, 2025Total Current Liabilities
35.23BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
7.27BUSDFY2025 · Dec 31, 2025Accounts Receivable
17.76BUSDFY2025 · Dec 31, 2025Inventory
13.74BUSDFY2025 · Dec 31, 2025Accounts Payable
5.38BUSDFY2025 · Dec 31, 2025Short-term Debt
1.64BUSDFY2025 · Dec 31, 2025Other Current Liabilities
8.46BUSDFY2025 · Dec 31, 2025Long-term Debt
40.87BUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
3.97BUSDFY2025 · Dec 31, 2025Common Stock (Book)
590.00MUSDFY2025 · Dec 31, 2025Retained Earnings
24.47BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
26.54BUSDvs all stocks (USD)
52-Week Low
712.05USDUpdated Aug 27, 202652-Week High
1.29KUSDUpdated Aug 27, 202652-Week Change
60.68%vs all stocks
Beta
0.5060xvs all stocks
50-Day MA
1.18KUSDUpdated Aug 27, 2026200-Day MA
1.06KUSDUpdated Aug 27, 2026Avg 10-Day Volume
2.39MSharesUpdated Aug 27, 2026Avg 30-Day Volume
2.64MSharesUpdated Aug 27, 2026Diluted EPS (TTM)
29.48USDUpdated Aug 27, 2026Other Income / Expense
-3.96BUSDFY2025 · Dec 31, 20255 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Diagnostic
Elevated EBITDA Margin With Small D&A Gap and Capex Above Depreciation
EBITDA margin reads high with little depreciation charged, and capex above that charge.
Reads
Cash Backing With Revenue And Income Streaks
Revenue has risen in each of three years, profit in all three, and it holds more cash than debt.
Reads
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
Revenue Growth With Elevated Margin
Revenue up in each of five years, while its operating margin stays high.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 9.29: safe zoneNotable
Altman Z-Score: 9.29
High earnings qualityNotable
Earnings Quality Score: 0.96
High structural barrier to entryNotable
Barrier to Entry: 0.61
Supply Chain
Downstream position: depends on 11 industries, supplies 6Notable
Outgoing: 6.00Incoming: 11.00
High connectivity hub: 17 industry connectionsNotable
Total Connections: 17.00
Scale
Market cap is $1.05T, higher than 95% of all stocks globallySignificant
Market cap (USD): 1,048,777,046,194Global P95: 26,266,743,019.727
Revenue is $79.67B, higher than 95% of all stocks globallySignificant
Revenue (USD): 79,666,003,968Global P95: 15,102,391,082.578
Levered free cash flow is $11.07B, higher than 95% of all stocks globallySignificant
Levered free cash flow (USD): 11,065,900,032Global P95: 1,235,239,084.501
Companies that share the same coordination system — how they create, deliver, or capture value.
Johnson & Johnson
Tier 1ProductionApproval-Gated PipelineRuleFlow
AbbVie Inc.
Tier 1ProductionApproval-Gated PipelineRule
Merck & Co., Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Roche Holding AG Genussscheine
Tier 1ProductionApproval-Gated PipelineRuleRisk
Novartis AG
Tier 1ProductionApproval-Gated PipelineRuleRisk
AstraZeneca PLC
Tier 1ProductionApproval-Gated PipelineRuleFlow
Amgen Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Abbott Laboratories
Tier 1ProductionApproval-Gated PipelineRuleFlow
Gilead Sciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Pfizer Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
NVIDIA Corporation
5 interpretationsElevated EBITDA Margin With Small D&A Gap and Capex Above DepreciationCash Backing With Revenue And Income StreaksOperating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue, Profit, And Income GrowthRevenue Growth With Elevated Margin
Suzhou TFC Optical Communication Co., Ltd.
4 interpretationsCash Backing With Revenue And Income StreaksOperating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue, Profit, And Income GrowthRevenue Growth With Elevated Margin
Shanghai Bochuan Electronic Co., Ltd.
4 interpretationsCash Backing With Revenue And Income StreaksOperating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue, Profit, And Income GrowthRevenue Growth With Elevated Margin